Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Incidence of Nd:YAG capsulotomy of a hydrophobic glistening-free intraocular lens (MX60)

Poster Details

First Author: T.Tran FRANCE

Co Author(s):                        

Abstract Details

Purpose:

To evaluate the incidence of Nd:YAG capsulotomy over 3 years on a large series of eyes implanted with a hydrophobic intra-ocular lens (IOL) with 4% water content (MX60 IOL, Bausch + Lomb). The lens is designed with an aberration-free aspheric optic and a 360┬░posterior sharp square edge.

Setting:

Retrospective study in a university-based single center.

Methods:

Charts of 245 eyes of (149 patients) implanted with a hydrophobic acrylic IOL (MX60) from May 2011 to May 2013 were retrospectively reviewed. Following data were recorded: age at time of surgery, sex, surgical complications, associated ocular pathologies, date of Nd: YAG laser capsulotomy. All cataract surgeries were performed by a single surgeon. Only uneventful in-the -capsular bag implantations with a minimum of 24 months follow-up were included in the study. Time from IOL implantation to Nd: YAG laser capsulotomy was analyzed with Kaplan-Meier survival curves.

Results:

227 eyes of 143 patients fulfill the selection criteria: mean follow-up was 36 months (24 to 48 months), age ranged from 55 to 95 years, 67.7% were female, 31% reported associated ocular pathologies. 5 eyes of 227 (2.2%) had an Nd: YAG laser capsulotomy at 6, 9, 28, 28 and 41 months after implantation. Survival curves analysis will be available at the time of the presentation.

Conclusions:

In this retrospective series of 227 eyes, with a mean follow-up of 3 years, the MX60 IOL demonstrated to be effective in preventing posterior capsule opacification, with a 2.2% Nd: YAG capsulotomy rate.

Financial Disclosure:

One or more of the authors research is funded, fully or partially, by a competing company

Back to Poster listing